BLOG

endpoints

UPDATED: Merck makes first big splash for Alzheimer’s drug R&D since 2017 fail, inking research pact with Cerevance

For the first time since discontinuing its late-stage Alzheimer’s program, Merck has found promise on the path forward in the memory-robbing disease.